Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03076034 · ClinicalTrials.gov registry record · NA
Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk
A NA study of Osteoporosis and Hip Fractures, sponsored by Beth Israel Deaconess Medical Center.
- Active
- Registry status
- NA
- Development phase
- 190
- Enrollment target
- 1
- Study location
NCT03076034: Active NA study of Osteoporosis and Hip Fractures, sponsored by Beth Israel Deaconess Medical Center.
NCT03076034 is a NA study of Osteoporosis and Hip Fractures that is active but no longer recruiting, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 190 participants, below the 1,544-participant average among 84 other Osteoporosis trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03076034, a NA study of Osteoporosis and Hip Fractures, is active but no longer recruiting, sponsored by Beth Israel Deaconess Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine whether a new minimally invasive method for in vivo measurement of cortical bone tissue properties can identify those who are at risk for fragility fractures of the hip and radius. The investigators hypothesis is that women with fragility fractures of the hip and radius have altered cortical bone tissue properties compared to non-fracture controls independent of standard clinical tests, such as bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA).
Primary Outcome
Osteoprobe measurement
Conditions Studied
Interventions
- DEVICE Reference Point Indentation
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2015-01-26 |
| Est. Completion | 2028-11 |
| Phase | NA |
What the registry record for NCT03076034 still lists
NCT03076034 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 1,544-participant average among 84 other Osteoporosis trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Osteoporosis appearing as the primary indexed condition, and to 1 intervention - of which Reference Point Indentation is the first listed.
NCT03076034 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03076034 about?
NCT03076034 is a clinical study titled "Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk". The objective of this study is to determine whether a new minimally invasive method for in vivo measurement of cortical bone tissue properties can identify those who are at risk for fragility fractures of the hip and radius. The investigators hypothesis is that women with fragility fractures of the ...
What is the current status of trial NCT03076034?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 190 participants. The study started on 2015-01-26. Estimated completion is 2028-11.
What conditions does trial NCT03076034 study?
This clinical trial studies the following conditions: Osteoporosis, Hip Fractures, Distal Radius Fracture.
What interventions are being tested in trial NCT03076034?
The interventions under investigation include: Reference Point Indentation (DEVICE).
Who is sponsoring clinical trial NCT03076034?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03076034 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03076034's enrollment target sits among peer trials
190 31st of 84 higher than 54 of 84 other Osteoporosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoporosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
OsteoPorotic fracTure preventION System (OPTIONS) Research Study
RECRUITING · NA
-
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
RECRUITING · NA
-
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
RECRUITING · NA
-
Mode of Exercise and Bone Biomarkers in Older Veterans
RECRUITING · NA
-
Synbiotic to Attenuate Resorption of the Skeleton
RECRUITING · NA
-
Sickle Cell Disease (SCD) Bone Pain Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI